高度門脈腫瘍栓（Vp3/4）を伴う進行肝細胞癌に対してのソラフェニブ投与の治療成績
スポンサーリンク
概要
- 論文の詳細を見る
We investigated efficacy of sorafenib therapy for advanced hepatocellular carcinoma (HCC) with Vp3/4 portal vein tumor thrombosis. According to modified RECIST, the therapeutic responses in Vp0/2 group (n=30) were 8 PR, 14 SD and 8 PD cases, and while those in Vp3/4 group (n=11) were 5 PR, 2 SD and 4 PD cases. The response rates and cumulative progression rates were not significantly different between two groups. The cumulative survival rates in Vp3/4 group were significantly lower than those in Vp0/2 group. The deteriorations of Child-Pugh scores in Vp3/4 group were significantly higher than those in Vp0/2 group. The possibility of the deterioration of liver function should be kept in mind during sorafenib therapy for advanced HCC with Vp3/4.
論文 | ランダム
- 遮音構造の実験的研究に用いる遮音カバ-の形状の効果について
- 穴のあいた遮音カバ-の遮音量の計算方法
- グラスウ-ルまたはもみがらによる板振動の抑制とその遮音効果への寄与に関する予備実験
- 遮音カバ-におけるもみがらの利用
- 積層遮音材におけるグラスウ-ルによる吸音と振動抑制の効果の比較